Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

"Retrospective Study of the Risk of Pathology in the Mandibular Second Molar Associated With an Impacted Third Molar: Development and Validation of a Semi-Automated Artificial Intelligence-Based Digitisation Platform". (SMART-M3)

8 novembre 2026 aggiornato da: Carlos Pérez-Albacete Martínez, Universidad Católica San Antonio de Murcia

Impacted mandibular third molars (wisdom teeth that cannot fully erupt) may damage the adjacent second molar, causing decay on its back surface, loss of the supporting bone or resorption of its root. These problems are often silent and are detected late. This retrospective observational study aims to identify which radiographic features of the impacted third molar are associated with a higher risk of pathology in the second molar.

The study uses panoramic radiographs (OPG) and cone-beam computed tomography (CBCT) scans that were previously obtained for clinical reasons at the UCAM Dental University Clinic (Murcia, Spain) between 2018 and 2026. No new images or procedures are performed on patients. The position, angulation, depth and contact of the third molar with the second molar are measured, and their relationship with second molar pathology is analysed. The study also compares the information provided by OPG and CBCT and develops and validates a semi-automated, artificial intelligence-based platform to help clinicians make these radiographic measurements faster and more consistently.

Panoramica dello studio

Descrizione dettagliata

Design. Single-centre, observational, cross-sectional, retrospective study approved by the Ethics Committee of the Universidad Católica San Antonio de Murcia (code CE102517). It follows the Declaration of Helsinki. Informed consent was waived because only pre-existing images obtained for clinical purposes are used. Data are pseudonymised in accordance with Regulation (EU) 2016/679 (GDPR) and Spanish Organic Law 3/2018.

Setting and sample. Consecutive sampling of all eligible images acquired at the UCAM Dental University Clinic between February 2018 and June 2026 with an ORTHOPHOS SL 3D unit (Dentsply Sirona). The unit of analysis is the mandibular third molar, so each patient may contribute one to four records (one or two third molars, on OPG, CBCT or both). The expected sample is approximately 2,110 third molars from 1,188 patients on OPG and approximately 690 third molars from 384 patients on CBCT, with a paired OPG-CBCT subsample of 667 teeth.

Variables. Third molar variables are:

  • Winter classification
  • Pell & Gregory depth and ramus relationship
  • Retromolar space
  • Angle between the long axes of the second and third molars
  • Distance from the distal surface of the second molar to the ramus
  • Mesiodistal diameter of the third molar
  • Presence, type and level of contact between the third and second molars Covariates are age, sex and smoking status. Outcome. The primary outcome is a composite of distal pathology of the mandibular second molar, defined as the presence of at least one of the following: distal caries, distal bone loss or external root resorption. Teeth without any of the three are classified as controls. Each component is also recorded separately, with its extent or severity.

Statistical analysis. The analysis comprises:

  • Descriptive statistics, overall and by imaging modality.
  • Bivariate analysis using chi-square or Fisher's exact tests and Mann-Whitney U or Student's t tests, with odds ratios, 95% confidence intervals and correction for multiple comparisons.
  • Multivariable mixed-effects logistic regression with the patient as a random effect, to account for the clustering of teeth within patients.
  • Assessment of the model's discrimination with ROC curves and AUC.
  • Agreement between OPG and CBCT in the paired subsample, using intraclass correlation coefficients, simple and weighted kappa and Bland-Altman analysis, with 95% confidence intervals obtained by patient-clustered bootstrap.
  • Intra-observer reliability on 123 teeth per modality. AI-based platform. A semi-automated digitisation platform based on artificial intelligence (automatic landmark detection) is developed to perform the radiographic measurements. It is validated against expert manual assessment in an independent subsample of 191 third molars (103 OPG and 88 CBCT).

Tipo di studio

Osservativo

Iscrizione (Effettivo)

1188

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Murcia
      • Murcia, Murcia, Spagna, 30008
        • Clínica Universitaria UCAM Dental

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Adult patients (18 years or older) who attended the UCAM Dental University Clinic (Murcia, Spain) between February 2018 and June 2026 and had at least one mandibular third molar visible on a panoramic radiograph (OPG) and/or cone-beam computed tomography (CBCT) scan obtained previously for clinical purposes. Patients were identified consecutively through the clinic's records management software (GESDEN).

Descrizione

Inclusion Criteria:

  • Age 18 years or older.
  • Age and sex recorded.
  • At least one mandibular third molar present.
  • OPG and/or CBCT available.

Exclusion Criteria:

  • Absence of the adjacent second mandibular molar.
  • Insufficient diagnositc image quality.
  • Previous surgery altering the anatomy.
  • Cysts or tumours in the third molar region.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: RETROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
OPG cohort

Patients with an impacted mandibular third molar assessed on panoramic radiography.

The radiographic assessment was performed on images that were already available. No additional exposure was required.

CBCT cohort

Subset of patients also assessed on CBCT.

The radiographic assessment was performed on images that were already available. No additional exposure was required.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Primary
Lasso di tempo: At the time of the radiographic examination (single cross-sectional assessment).

Composite distal pathology of the mandibular second molar (distal caries, distal bone loss and/or external root resorption).

At the time of the radiographic examination (single cross-sectional assessment).

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Secondary
Lasso di tempo: At the time of the radiographic examination (single cross-sectional assessment).

Agreement between OPG and CBCT measurements (ICC, weighted kappa, Bland-Altman).

At the time of the radiographic examination (single cross-sectional assessment).

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

31 ottobre 2025

Completamento primario (Effettivo)

30 luglio 2026

Completamento dello studio (Stimato)

15 dicembre 2026

Date di iscrizione allo studio

Primo inviato

8 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

8 novembre 2026

Primo Inserito (Effettivo)

13 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

13 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

8 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Pseudonymised clinical images subject to GDPR; data available from the corresponding author upon reasonable request.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi